🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

36,04 USD

Máx. histórico

41,81

55 días

Caída desde máximo

-13,80%

Rango 52 semanas

19,32 – 42,50

Variación hoy

+0,42%

Cierre anterior

35,89

Rango de hoy

35,56 – 36,78

Volumen hoy

6.686.435

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,48%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 13 horas
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
19/12/2023 11,01 11,13 10,78 10,80 -1,01% 3,18% 4.590.700
18/12/2023 11,11 11,27 10,87 10,91 -2,24% 3,56% 3.894.900
15/12/2023 11,19 11,34 11,04 11,16 +0,27% 2,68% 9.135.800
14/12/2023 11,05 11,19 10,70 11,13 +2,96% 4,43% 7.225.900
13/12/2023 10,38 10,91 10,30 10,81 +4,44% 5,88% 5.648.600
12/12/2023 10,00 10,41 9,82 10,35 +4,23% 5,90% 5.696.900
11/12/2023 9,73 9,97 9,69 9,93 +1,02% 2,88% 3.382.900
08/12/2023 9,74 9,84 9,48 9,83 +0,82% 3,70% 4.957.300
07/12/2023 9,78 9,89 9,70 9,75 -0,51% 1,94% 4.469.800
06/12/2023 9,96 10,05 9,74 9,80 -0,20% 3,11% 4.585.900
05/12/2023 9,85 9,97 9,64 9,82 -1,21% 3,35% 3.055.400
04/12/2023 9,80 10,01 9,70 9,94 +0,91% 3,16% 4.617.900
01/12/2023 9,57 9,87 9,34 9,85 +3,03% 5,54% 4.612.300
30/11/2023 9,49 9,84 9,44 9,56 +1,59% 4,16% 8.367.400
29/11/2023 9,13 9,56 9,13 9,41 +3,52% 4,71% 5.063.600
28/11/2023 9,09 9,15 8,87 9,09 -0,11% 3,08% 7.078.600
27/11/2023 8,83 9,13 8,61 9,10 -0,33% 5,82% 7.194.100
24/11/2023 9,03 9,28 9,00 9,13 +1,44% 3,10% 2.012.800
22/11/2023 8,70 9,05 8,65 9,00 +4,17% 4,66% 4.895.900
21/11/2023 8,75 8,81 8,56 8,64 -1,82% 2,86% 3.803.200
20/11/2023 8,91 9,05 8,77 8,80 -1,90% 3,14% 3.224.100
17/11/2023 9,03 9,09 8,84 8,97 -0,55% 2,77% 5.536.400
16/11/2023 9,05 9,14 8,93 9,02 -0,55% 2,38% 6.232.500
15/11/2023 9,25 9,52 9,04 9,07 -2,47% 5,19% 4.522.600
14/11/2023 9,40 9,60 9,16 9,30 +2,76% 4,68% 4.994.600
13/11/2023 8,64 9,14 8,47 9,05 +2,72% 7,81% 4.145.100
10/11/2023 8,60 8,84 8,59 8,81 +3,04% 2,91% 3.164.200
09/11/2023 9,01 9,08 8,51 8,55 -4,79% 6,33% 5.398.400
08/11/2023 9,11 9,11 8,73 8,98 -1,21% 4,23% 3.959.400
07/11/2023 8,94 9,18 8,80 9,09 +2,25% 4,25% 4.423.300